Catherine Legrand

3.3k total citations · 1 hit paper
54 papers, 2.5k citations indexed

About

Catherine Legrand is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Statistics and Probability. According to data from OpenAlex, Catherine Legrand has authored 54 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 10 papers in Statistics and Probability. Recurrent topics in Catherine Legrand's work include Occupational and environmental lung diseases (12 papers), Statistical Methods and Inference (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Catherine Legrand is often cited by papers focused on Occupational and environmental lung diseases (12 papers), Statistical Methods and Inference (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Catherine Legrand collaborates with scholars based in Belgium, France and Netherlands. Catherine Legrand's co-authors include Jan P. van Meerbeeck, Giuseppe Giaccone, C. Debruyne, Rabab Gaafar, Andrew Bottomley, Christian Manegold, Mark Vincent, Per Carlsson, Eric A. Van Marck and Rob J. van Klaveren and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Catherine Legrand

52 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

2005 474 citations Jan P. van Meerbeeck, Rabab Gaafar et al. profile →

Peers

Countries citing papers authored by Catherine Legrand

Since Specialization

Citations

This map shows the geographic impact of Catherine Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Legrand more than expected).

Fields of papers citing papers by Catherine Legrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Legrand. The network helps show where Catherine Legrand may publish in the future.

Co-authorship network of co-authors of Catherine Legrand

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Legrand. A scholar is included among the top collaborators of Catherine Legrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Legrand. Catherine Legrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations 2023 ·JCI Insight ·Emmanuel Seront, An Van Damme, Catherine Legrand, (unknown), Philippe Orcel, Thomas Funck‐Brentano, Marie‐Antoinette Sevestre, A. Dompmartin, I. Quéré, Pascal Brouillard, Nicole Revençu, (unknown), Frank Hammer, Philippe Clapuyt, Dana Dumitriu, Miikka Vikkula, Laurence M. Boon	28
2	Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans 2019 ·Vaccine ·Wivine Burny, Arnaud Marchant, Caroline Hervé, Andrea Callegaro, (unknown), Laurence Fissette, Lien Gheyle, Catherine Legrand, Cheikh Ndour, Fernanda Tavares Da Silva, Robbert van der Most, Fabienne Willems, Arnaud M. Didierlaurent, Juan Pablo Yarzábal	51
3	Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy 2016 ·European Journal of Cancer ·Isabelle Tromme, Catherine Legrand, Brecht Devleesschauwer, Ulrike Leiter, Stefan Suciu, Alexander M.M. Eggermont, (unknown), Jean‐François Baurain, L. Thomas, Philippe Beutels, Niko Speybroeck	10
4	Melanoma burden by melanoma stage: Assessment through a disease transition model 2015 ·European Journal of Cancer ·Isabelle Tromme, Catherine Legrand, Brecht Devleesschauwer, Ulrike Leiter, Stefan Suciu, Alexander M.M. Eggermont, Julie Francart, (unknown), Juanita A. Haagsma, Jean‐François Baurain, L. Thomas, Philippe Beutels, Niko Speybroeck	18
5	Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Atypical Nevi 2014 ·PLoS ONE ·Isabelle Tromme, Brecht Devleesschauwer, Philippe Beutels, Pauline Richez, Nicolas Praet, (unknown), Liliane Marot, (unknown), Ivan Théate, Jean‐François Baurain, Julien Lambert, Catherine Legrand, L. Thomas, Niko Speybroeck	22
6	Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study 2012 ·British Journal of Dermatology ·Isabelle Tromme, (unknown), (unknown), Catherine Legrand, Liliane Marot, Philippe M. Vereecken, Ivan Théate, P. Van Eeckhout, Pauline Richez, J.F. Baurain, L. Thomas, Niko Speybroeck, (unknown)	66
7	Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? 2011 ·European Journal of Anaesthesiology ·Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, (unknown), (unknown), Catherine Legrand, Paul Van Cangh, Jean‐Pierre Cosyns, Marc De Kock	85
8	Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma 2011 ·Journal of Thoracic Oncology ·Kevin Hollevoet, Kristiaan Nackaerts, Robert C. Gosselin, Walter De Wever, Lionel Bosquée, Paul De Vuyst, Paul Germonpré, Eliane Kellen, Catherine Legrand, Yoshiro Kishi, Joris Delanghe, Jan P. van Meerbeeck	66
9	Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma 2010 ·American Journal of Respiratory and Critical Care Medicine ·Kevin Hollevoet, Kristiaan Nackaerts, J. Thimpont, Paul Germonpré, Lionel Bosquée, Paul De Vuyst, Catherine Legrand, Eliane Kellen, Yoshiro Kishi, Joris Delanghe, Jan P. van Meerbeeck	78
10	Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis 2010 ·Anesthesia & Analgesia ·Patrice Forget, (unknown), Martine Berlière, Jean‐Pascal Machiels, (unknown), Catherine Legrand, Marc De Kock	171
11	Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study 2009 ·Journal of Thoracic Oncology ·Kevin Hollevoet, Eliane Kellen, Kristiaan Nackaerts, J. Thimpont, Paul Germonpré, Paul De Vuyst, Lionel Bosquée, Joris Delanghe, Catherine Legrand, Jan P. van Meerbeeck	1
12	A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials 2009 ·European Journal of Cancer ·Julie Francart, (unknown), Séverine Henrard, Catherine Legrand, Paul Baas, Rabab Gaafar, Jan P. van Meerbeeck, Richard Sylvester, Annie Robert	35
13	Validation of prognostic indices using the frailty model 2008 ·Lifetime Data Analysis ·Catherine Legrand, Luc Duchateau, Paul Janssen, Vincent Ducrocq, (unknown)	6
14	Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction 2007 ·CHEST Journal ·George Philip, David S. Pearlman, César Villarán, Catherine Legrand, Tom Loeys, Ronald B. Langdon, Theodore F. Reiss	36
15	Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975 2006 ·Annals of Oncology ·Fabio Efficace, Andrew Bottomley, Egbert F. Smit, P. Lianes, Catherine Legrand, C. Debruyne, Franz M.N.H. Schramel, Henk Smit, Rabab Gaafar, Bonne Biesma, C. Manegold, Corneel Coens, Giuseppe Giaccone, Jan P. van Meerbeeck	150
16	Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer 2006 ·Lung Cancer ·Veerle Surmont, R.J. van Klaveren, (unknown), (unknown), C. Manegold, Catherine Legrand, Paul Van Schil, Jan P. van Meerbeeck	9
17	Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer 2003 ·European Journal of Cancer ·Mary O’Brien, Ted A.W. Splinter, Egbert F. Smit, Bonne Biesma, Maciej Krzakowski, Vivianne C. G. Tjan‐Heijnen, Aart van Bochove, (unknown), (unknown), C. Debruyne, Catherine Legrand, Giuseppe Giaccone	46
18	Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling 1994 ·Journal of Veterinary Pharmacology and Therapeutics ·Pierre‐Louis Toutain, A. Autefage, Catherine Legrand, M. Alvinerie	86
19	Quantitative evaluation of an experimental inflammation induced with Freund's Complete Adjuvant in dogs 1994 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), Catherine Legrand, Didier Concordet, Robert L. Chevalier, Pierre‐Louis Toutain	13
20	Experimental Fusarial Hyalohyphomycosis in a Murine Model 1991 ·The Journal of Infectious Diseases ·Catherine Legrand, E. Anaissie, (unknown), P. Nelson, Gerald P. Bodey, (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact